Status:
NOT_YET_RECRUITING
Evaluating Dashboard-Integrated Pharmacist-Led Education on Improving Sacubitril/Valsartan Adherence in Heart Failure (PharmD ASSIST HFrEF)
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Heart Failure With Reduced Ejection Fraction (HFrEF)
Sacubitril/Valsartan
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The goal of this pragmatic clinical trial is to evaluate whether pharmacist-led education, integrated with interactive visualization dashboards, can enhance medication adherence in patients with heart...
Eligibility Criteria
Inclusion
- adults aged 20 or older
- a diagnosis of HFrEF, which is defined by a left ventricular ejection fraction of 40% or less
- currently receiving sacubitril/valsartan at the time of recruitment
- receiving care at the cardiology department or cardiology ward at National Taiwan University Hospital
- referral from the clinicians at National Taiwan University Hospital
Exclusion
- unable or unwilling to provide informed consent, adhere to study protocols, or complete required questionnaires in person during three scheduled visits (i.e., 3, 6, 12 months after the baseline measurement)
- having received care at the pharmacist-led HF clinic at National Taiwan University Hospital
Key Trial Info
Start Date :
April 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06900803
Start Date
April 7 2025
End Date
October 31 2027
Last Update
April 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.